Familial hypercholesterolaemia trials in Türkiye
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleLong-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
- Where
- Adana, Ankara, Istanbul, Izmir
- Age
- 2 years to 100 years
- People
- 195 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05682378 - Phase 3Not yet taking people in TürkiyeLong-Term Efficacy and Safety of Lerodalcibep in Children and Adolescents With Familial Hypercholesterolemia
- Where
- Izmir
- Age
- 6 years to 17 years
- People
- 150 worldwide
- Run by
- LIB Therapeutics LLC
See details and how to joinNCT07775339 · EU 2026-528022-38-00 - No phaseTaking peopleAssessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)
- Where
- Bornova
- Age
- 12 years and over
- People
- 52 worldwide
- Run by
- Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
See details and how to joinNCT07447648 - Phase 3Taking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Adana, Ankara, Izmir
- Age
- 2 years to 11 years
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006 - Phase 3Taking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Adana, Ankara, Izmir
- Age
- 6 years to 11 years
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019